Caplin Point Laboratories Ltd (BOM:524742)
₹ 2010.85 -106.65 (-5.04%) Market Cap: 152.85 Bil Enterprise Value: 144.14 Bil PE Ratio: 31.03 PB Ratio: 6.01 GF Score: 98/100

Q4 2020 Caplin Point Laboratories Ltd Earnings Call Transcript

Jun 18, 2020 / 10:30AM GMT
Release Date Price: ₹368.9 (-4.44%)
Operator

Ladies and gentlemen, good day, and welcome to the Caplin Point Laboratories Q4 and FY '20 Earnings Conference Call hosted by Haitong Securities India. (Operator Instructions) Please note that this conference is being recorded.

I now hand this conference over to Mr. Amey Chalke, pharma analyst of Haitong. Thank you, and over to you, sir.

Amey Chalke
Haitong International Research Limited - Research Analyst

Thanks, Nirav. Welcome to 4Q FY '20 earnings call of Caplin Point Laboratories. From the management side, we have Mr. C.C. Paarthipan, Chairman; Mr. Vivek Partheeban, Chief Operating Officer; Dr. Sridhar Ganesan, Managing Director; Mr. D. Muralidharan, CFO; Mr. M. Sathya Narayanan, Deputy CFO; Mr. Vinod Kumar, Company Secretary. Over to you, Vivek. Thank you.

Vivek Partheeban;Chief Operating Officer

Thank you, Amey. Hello, and good evening, everyone, and I am pleased to welcome you to our earnings call to discuss our Q4 and full year '19/'20 results. Please note that a copy of all our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot